申请人:Cohen Frederick
公开号:US20060276435A1
公开(公告)日:2006-12-07
Amino terminus-blocked peptide boronate compounds of Formulas I and II are useful for inhibiting Fibroblast Activation Protein (FAP) and other proteases, and for treating disorders mediated by FAP. Methods of using the amino terminus blocked peptide boronate compounds, and stereoisomers, tautomers, solvates and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
公式 I 和 II 的氨基末端阻断肽硼酸化合物可用于抑制成纤维细胞活化蛋白(FAP)和其他蛋白酶,并用于治疗由FAP介导的疾病。公开了使用氨基末端阻断肽硼酸化合物以及其立体异构体、互变异构体、溶剂合物和药用可接受的盐来进行体外、原位和体内对哺乳动物细胞中的这些疾病进行诊断、预防或治疗的方法,或相关的病理状况。